This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Fundacao Oswaldo Cruz. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Thiago Moreno Lopes E Souza: Innovator in HIV Treatment
Introduction
Thiago Moreno Lopes E Souza is a notable inventor based in Rio de Janeiro, Brazil. He has made significant contributions to the field of medical research, particularly in the development of compounds for the treatment of HIV and related infections. His innovative work has the potential to impact the lives of many individuals affected by these diseases.
Latest Patents
Thiago holds a patent for isatin-derived compounds, which are utilized for the treatment of AIDS. The patent details the use of these compounds, which consist of various isatin derivatives, specifically designed to inhibit HIV. The compounds are also applicable in treating infections caused by HBV or co-infections involving both HIV and HBV. This invention represents a significant advancement in the search for effective treatments against these viruses.
Career Highlights
Thiago is associated with the Fundação Oswaldo Cruz, a prominent research institution in Brazil. His work there has allowed him to focus on innovative solutions to pressing health issues. His dedication to research and development in the field of virology has positioned him as a key figure in the fight against HIV.
Collaborations
Thiago has collaborated with esteemed colleagues, including Mônica Macedo Bastos and Nubia Boechat. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking discoveries in the field.
Conclusion
Thiago Moreno Lopes E Souza is a pioneering inventor whose work in developing HIV-inhibiting compounds showcases his commitment to advancing medical science. His contributions are vital in the ongoing battle against viral infections, and his innovative spirit continues to inspire future research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile